CJC-1295 No DAC 5MG
CJC-1295 (No DAC) is a short-acting GHRH analog used in endocrine and metabolic research. It supports investigation of natural, pulsatile growth hormone release and IGF-1 signaling pathways. Widely utilized in pituitary, aging, and hormonal regulation research models. Supplied as high-purity lyophilized powder for laboratory research use only.
$65.00
Satisfaction Guaranteed
Secure
Payment
Third-party
Tested
⚠️ RESEARCH USE ONLY
This product is for R&D purposes only and is not approved for human or veterinary use.
CJC-1295 (No DAC) 5MG – GHRH Analog for Endocrine Research
Quantum Biogenix presents research-grade CJC-1295 (No DAC), a synthetic analog of Growth Hormone–Releasing Hormone (GHRH) developed for short-acting endocrine and metabolic research applications. This compound enables precise investigation of pulsatile growth hormone release, pituitary signaling, and IGF-1 modulation in controlled laboratory environments.
Unlike DAC-modified variants, CJC-1295 (No DAC) exhibits a shorter biological half-life, allowing researchers to study natural growth hormone pulse dynamics without prolonged receptor activation. This makes it a valuable tool for examining physiological hormone release patterns and feedback mechanisms in endocrine research models.
| Product Name | CJC-1295 (No DAC) |
| Category | GHRH Analog Research Peptide |
| Form | Lyophilized Peptide Powder |
| Purity | ≥98% HPLC Verified |
| Application | Endocrine & Hormonal Regulation Research |
| Usage | Laboratory Research Only |
Scientific Overview of CJC-1295 (No DAC)
- Synthetic analog of Growth Hormone–Releasing Hormone (GHRH)
- Short-acting peptide without Drug Affinity Complex (DAC)
- Stimulates natural pulsatile growth hormone release
- Supports investigation of pituitary and IGF-1 signaling pathways
- High-purity peptide suitable for controlled laboratory studies
Key Research Applications
- Endocrine Signaling Studies – Analysis of growth hormone secretion patterns and pituitary response.
- IGF-1 Pathway Research – Investigation of downstream hormonal signaling and metabolic effects.
- Pulsatile Hormone Release Models – Study of physiological hormone rhythms and feedback regulation.
- Metabolic Regulation Research – Examination of growth hormone influence on lipid and glucose metabolism.
- Aging & Hormonal Function Studies – Evaluation of endocrine changes in experimental aging models.
Laboratory Handling & Storage
- Form: Lyophilized peptide powder
- Purity: ≥98% (HPLC verified)
- Recommended Storage: Store frozen or refrigerated, protected from moisture and light
- Handling: Reconstitute using sterile laboratory-grade solvents under aseptic conditions
- Stability: Maintain sealed and dry until research use
Mechanism of Research Interest
CJC-1295 (No DAC) binds to GHRH receptors in the anterior pituitary, triggering short-duration stimulation of endogenous growth hormone release. Its rapid clearance allows investigation of natural hormonal pulsatility rather than sustained elevation.
Experimental findings suggest that this short-acting mechanism provides insight into physiological growth hormone signaling, IGF-1 modulation, and metabolic regulation without prolonged receptor engagement. These characteristics make CJC-1295 (No DAC) an important research tool in endocrine and metabolic pathway studies.
Why Choose Quantum Biogenix?
- High-purity research peptides
- Batch-tested laboratory-grade compounds
- Reliable sourcing and quality verification
- Research-focused formulation standards
- Professional laboratory supply chain handling
Research Use Only Notice
This product is supplied strictly for laboratory research use. It is not intended for human consumption, medical use, or veterinary application. Researchers must comply with institutional and laboratory safety regulations during handling and experimentation.
Scientific References
- Thorner M.O. et al. (1997). Growth hormone–releasing hormone and pituitary regulation. Endocrine Reviews.
- Teichman S.L. et al. (2006). GHRH analogs and pulsatile growth hormone secretion. Journal of Clinical Endocrinology & Metabolism.
- Veldhuis J.D. et al. (2008). Physiological control of growth hormone secretion. Molecular and Cellular Endocrinology.
| Size | 10MG, 20MG |
|---|
Reviews
There are no reviews yet.